Ipsen bolsters executive leadership with two new recruits
pharmafile | April 12, 2018 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | appointment, ipsen, pharma
Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will join the company as Executive Vice President, Chief Business Officer, while Régis Mulot joins as Executive Vice President, Chief Human Resources Officer.
Previously serving at Axcella Health as Executive Vice-President, Chief Strategy and Corporate Development Office, Dr Magovčević-Liebisch brings two decades of senior biopharma management experience to the French firm, specialising in corporate partnering, M&A, pipeline and product portfolio development, legal and IP strategy.
Earlier in her career, she worked with Teva from 2013 to 2017 as its Senior Vice President and Head of Global Business Development, leading the licensing and acquisition of drug candidates, commercial products and companies, among other responsibilities. Prior to this, she also served at Dyax, which was later acquired by Shire in 2015, from 2001 in a range of roles including Executive Vice-President and Chief Operating Officer.
Mulot arrives at Ipsen from retail firm Staples, leaving his previous role as Executive Vice-President, Chief Human Resources Officer. In the position, he was responsible for a global HR team of over 600. He had served the company since 2009. Prior to this, Mulot worked in a HR leadership capacity at clothing firm Levi Strauss from 2002 to 2008 and tech start-up Broadnet Europe from 2000 to 2002. Earlier in his career he also had tenures at GTECH Corporation, International Post Corporation and Chronopost.
“I am delighted to welcome these two highly talented leaders to our executive team; both Ivana and Régis will play pivotal roles in the next phase of Ipsen’s transformation,” commented Ipsen CEO David Meek. Ivana has a strong track record in corporate business development and will bring further expertise to drive our external innovation and partnering strategy. Régis is an experienced international HR leader who will bring his passion for talent and organisational innovation to help further shape our One Ipsen culture.
“I would also like to take this opportunity to recognise Christophe Jean for his many contributions to Ipsen as Executive Vice-President, Strategy and Business Development,” he added. “Since joining the company in 2002 Christophe has played a key role for Ipsen and we wish him a successful and fulfilling retirement.”
Related Content
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
Johnson & Johnson announces successful results from trial for myeloma treatment
Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …
Ipsen’s Iqirvo approved for use in NHS Scotland to treat rare liver disease
The Scottish Medicines Consortium (SMC) has accepted the use of Ipsen’s Iqirvo (elafibranor) in NHS …
